News Releases

2008

Oct.17,2008 Ono Enters into License Agreement with Progenics (81.5KB)
Oct.01,2008 Announcement on Results of Phase II / III Clinical Study in Japan with Arocyte for Injection for Treatment of Acute Ischemic Stroke (47.9KB)
Sep.22,2008 Announcement on Completion of Acquisition of the Company's Own Shares (85.7KB)
Aug.05,2008 Revisions of First Half / Full Year Business Forecasts for FY 2008 (74.3KB)
Aug.05,2008 Announcement on Changes of Representative Directors and Members of the Board of Directors (121KB)
Jun.03,2008 Preliminary Data from Ongoing Phase 1 Trial of Investigational Fully Human Anti-PD-1 Antibody “ONO-4538/MDX-1106” Presented at American Society of Clinical Oncology (107KB)
May.14,2008 Announcement on Changes of Representative Directors and Members of the Board of Directors (115KB)
May.14,2008 Announcement on Partial Amendments to the Articles of Incorporation (66.0KB)
May.08,2008 Ono Resolved Increase in Dividends Projected for Fiscal 2007(the 60th Fiscal Term ending on March 31st,2008) (129KB)
Apr.17,2008 Discontinuation of Development for an Additional Indication of Cervical Spondylosis of Limaprost Alfadex,an Oral Prostaglandin E1 Derivative Preparation (53.0KB)
Apr.14,2008 Functionality Expansion of Ono Pharma USA, Inc., which is Ono's US Development Base (56.5KB)
Apr.14,2008 Announcement on Acquisition of the Company's Own Shares (59.9KB)
Mar.27,2008 Ono Enters into New Fragment-Based Drug Discovery Agreement on a Protease Target with Evotec AG (66.3KB)